News Announcement

Sai Life Sciences: Board Meeting Outcome for Outcome Of The Board Meeting Dated 06 February 2025

Pursuant to Regulation 30 33 and any other provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on Thursday 06 February 2025 inter-alia considered and approved the following:1. Un-audited Financial Results (Standalone and Consolidated) of the Company and noted the Limited Review Reports of the Statutory Auditors M/s. Deloitte Haskins & Sells LLP for the quarter and nine months ended 31 December 2024. A copy of the same are enclosed herewith as Annexure.The Meeting of the Board of Directors was duly commenced at 6.30 PM (IST) and concluded at 9.15 PM (IST).

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month